We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
Cap. Flow
-$8.05B
Cap. Flow %
-2.38%
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 26.36%
2 Consumer Discretionary 12.42%
3 Healthcare 12.26%
4 Financials 12.2%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YPF icon
2976
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$682K ﹤0.01%
178,500
-280,166
-61% -$1.17M
EVCM icon
2977
EverCommerce
EVCM
$1.93B
$678K ﹤0.01%
42,156
-14,301
-25% -$255K
INST
2978
DELISTED
Instructure Holdings, Inc.
INST
$678K ﹤0.01%
30,125
+2,472
+9% +$59.8K
TK icon
2979
Teekay
TK
$985M
$677K ﹤0.01%
221,352
-35,035
-14% -$121K
OYST
2980
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$672K ﹤0.01%
52,905
-6,079
-10% -$77.1K
RYAAY icon
2981
Ryanair
RYAAY
$31.3B
$671K ﹤0.01%
16,395
FSBW icon
2982
FS Bancorp
FSBW
$320M
$670K ﹤0.01%
20,154
-2,264
-10% -$77.5K
FTSI
2983
DELISTED
FTS International, Inc. Common Stock
FTSI
$670K ﹤0.01%
25,592
-3,535
-12% -$93.2K
NODK icon
2984
NI Holdings
NODK
$320M
$668K ﹤0.01%
35,482
-1,761
-5% -$34K
QTTB icon
2985
Q32 Bio
QTTB
$464M
$668K ﹤0.01%
10,193
-619
-6% -$60.1K
VOR icon
2986
Vor Biopharma
VOR
$1.28B
$666K ﹤0.01%
2,712
-214
-7% -$61.7K
TNXP icon
2987
Tonix Pharmaceuticals
TNXP
$192M
$665K ﹤0.01%
3
ETNB
2988
DELISTED
89bio
ETNB
$664K ﹤0.01%
56,140
-4,152
-7% -$65.6K
CECO icon
2989
Ceco Environmental
CECO
$4.14B
$662K ﹤0.01%
111,030
-9,673
-8% -$64.2K
LYEL icon
2990
Lyell Immunopharma
LYEL
$360M
$662K ﹤0.01%
3,644
+1,354
+59% +$302K
VLGEA icon
2991
Village Super Market
VLGEA
$639M
$658K ﹤0.01%
30,399
-2,165
-7% -$48.4K
SYRE icon
2992
Spyre Therapeutics
SYRE
$9.25B
$653K ﹤0.01%
6,753
-433
-6% -$68.3K
ITI
2993
DELISTED
Iteris, Inc.
ITI
$653K ﹤0.01%
174,148
-12,602
-7% -$61K
DGICA icon
2994
Donegal Group Class A
DGICA
$714M
$643K ﹤0.01%
45,904
-7,575
-14% -$109K
NCMI icon
2995
National CineMedia
NCMI
$378M
$643K ﹤0.01%
25,683
-1,862
-7% -$59.3K
PSTX
2996
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$643K ﹤0.01%
97,594
-10,090
-9% -$68.7K
QURE icon
2997
uniQure
QURE
$3.22B
$640K ﹤0.01%
30,880
-4,295
-12% -$123K
IMUX icon
2998
Immunic
IMUX
$195M
$638K ﹤0.01%
7,538
-561
-7% -$50.5K
KRUS icon
2999
Kura Sushi USA
KRUS
$593M
$636K ﹤0.01%
9,846
HBIO icon
3000
Harvard Bioscience
HBIO
$29.2M
$631K ﹤0.01%
9,101
-2,745
-23% -$195K

Similar funds

Nuveen's Q4 2021 Portfolio in Review

As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
  • Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
  • Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
  • Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
  • Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
  • Nuveen opened 75 new positions and closed 162 in Q4 2021.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.